Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on Baclofen for Pulmonary and Sleep Disorders in Spinal Cord Injury Patients
The NetherlandsStudy on Ublituximab and Drug Combination for Patients with Myasthenia Gravis or Relapsing Multiple Sclerosis
PolandStudy on Cannabidiol as Add-on Therapy for Seizures in Patients Aged 1-65 with Tuberous Sclerosis Complex
PolandStudy on the Effects of Inebilizumab for Adults with Myasthenia Gravis
FranceStudy on Selumetinib for Children Aged 1 to 6 with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
GermanyStudy on the Long-term Safety of Cenobamate for Patients with Primary Generalized Tonic-Clonic Seizures
GermanyStudy on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
CzechiaStudy on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis
AustriaStudy of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis
FranceStudy on the Effectiveness and Safety of Oral Midazolam for Elderly Patients with Severe Neurocognitive Disorders and Care Resistance
FranceStudy on the Safety and Effects of AP-101 for Patients with Amyotrophic Lateral Sclerosis (ALS)
SwedenStudy on the Safety and Long-Term Effects of Efavirenz for Adults and Late-Onset Juvenile Niemann-Pick Type C Disease with Cognitive Impairment
SpainThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
